Ionizing Breast Imaging Technology Market Size to Grow At 7.6% CAGR From 2024 to 2030.

Ionizing Breast Imaging Technology Market size (2024-2030)

As per our research report, the Ionizing Breast Imaging Technology Market size is estimated to be growing at a CAGR of 7.6% from 2024 to 2030.

Mammograms have long been a prevalent ionizing imaging technology for detecting breast cancer. Utilized in breast cancer screening, mammograms can identify the disease in its early stages, even before symptoms manifest. These mammographic exams, which use X-ray beams—a type of ionizing radiation—produce images of the breast's interior. Significant technological advancements have emerged in mammography, including digital imaging methods like 3D, computed tomography (CT), and molecular breast imaging. Looking ahead, with the integration of artificial intelligence (AI), machine learning (ML), and other advanced imaging techniques, along with reduced radiation exposure, this market is poised for substantial growth.

Over the years, there have been numerous lifestyle alterations. Notably, there has been a significant increase in the consumption of tobacco and alcohol. The excessive intake of junk food has contributed to rising obesity rates. Additionally, exposure to harmful radiation from electronic devices has surged. Delaying pregnancy until after the age of 30 also poses a risk. Furthermore, the use of hormone therapy drugs that combine progesterone and estrogen for treating menopausal symptoms has been linked to an elevated risk of breast cancer. Genetic factors and family history further compound this threat. In the United States, breast cancer remains the most common disease among women, with an estimated 287,850 new cases expected in 2022. Early detection is crucial, prompting increased awareness among women and girls of all ages. Regular self-breast examinations are encouraged to detect lumps early.

Digital Breast Tomosynthesis (DBT), a multi-image platform, has replaced single-emulsion film as the primary mammography imaging method. This advancement has enabled radiologists to detect tumors more effectively, improving image quality. Since the implementation of DBT in 2011, call-back rates have decreased, and tumor detection rates have increased. Recently, the fields of artificial intelligence (AI) and machine learning (ML) have shown the potential to significantly enhance reading times and the accuracy of mammography screenings. AI-driven breast ultrasonography (US), detection algorithms, and computer-aided diagnosis (CAD) applications are anticipated to hold immense potential in this evolving field.

The COVID-19 pandemic negatively impacted the market. To curb the virus's spread, lockdowns, social distancing, and movement restrictions became the norm. Hospitals and clinics were overwhelmed with COVID-19 patients, leading to shortages of beds, oxygen supplies, and ventilators globally. Resources were redirected towards vaccine development and COVID-19 care facilities. Public fear of infection led to hesitancy in seeking in-person healthcare services. Additionally, widespread layoffs due to economic uncertainty and losses had a significant financial impact on many households.

In January 2023, Seno Medical and Genetik Inc. partnered to market, sell, and service Seno Medical's advanced Imagio Opto-Acoustic/Ultrasound (OA/US) Breast Imaging System. This innovative diagnostic system utilizes non-invasive optoacoustic/ultrasound technology to provide real-time information on breast lesions, enabling providers to characterize masses that may not require further invasive diagnostic evaluation. This technology allows physicians to differentiate between benign and malignant breast lesions effectively.

KEY MARKET INSIGHTS:

• Based on the Technology Type, mammography is regarded as the largest and fastest-growing market in breast cancer detection. This growth is driven by its established history, robust testing analysis, technological advancements, public awareness, and widespread accessibility. Among the techniques, 2D mammography remains a well-known and widely used method due to its high sensitivity and long-standing familiarity. Meanwhile, Digital Breast Tomosynthesis (DBT), or 3D mammography, is rapidly gaining popularity. This technique offers lower recall rates, enhanced visualization, increased precision and accuracy, regulatory approvals, and an improved patient experience.
• Based on the End-User, Hospitals and clinics are the leading end users in the market, accounting for approximately 67% of the total share. This dominance is attributed to the presence of skilled professionals, advanced infrastructure, high-quality treatments, stringent hygiene standards, significant investments, strategic partnerships, and well-equipped machinery. Conversely, diagnostic imaging centers represent the fastest-growing segment. This growth is driven by increasing awareness, effective diagnostic capabilities, cost-effective treatments, and expansion efforts in many underdeveloped and developing countries.
• Based on the region, North America is the largest region in the mammography market, holding an estimated share of around 37%. The United States and Canada are at the forefront, driving the region's success. Factors contributing to this success include technological advancements, widespread accessibility, increased public awareness, substantial investments, the presence of prestigious pharmaceutical companies and hospitals, and a rising incidence of cancer. However, the Asia-Pacific region is projected to be the fastest-growing. Countries like Japan, Singapore, Australia, and China are leading this growth. The primary reasons for this rapid expansion include governmental initiatives and funding, extensive research activities, improved healthcare access and infrastructure, educational programs, corporate collaborations, a rising number of cancer cases, and the emergence of new startups.
• Companies playing a leading role in the Ionizing Breast Imaging Technology Market profiled in this report are Hologic, Inc., Philips Healthcare, Siemens Healthineers, GE Healthcare, Fujifilm Medical Systems, and Canon Medical Systems Corporation.

Global Ionizing Breast Imaging Technology Market Segmentation:

By Technology Type:

• Mammography
• Positron Emission Mammography (PEM)
• Breast Computed Tomography (CT)
• Molecular Breast Imaging (MBI)
• Others

By End User:

• Hospitals and Clinics
• Diagnostic Imaging Centers
• Breast Care Centers
• Others

By Regional Analysis:

• North America
• Asia-Pacific
• Europe
• South America
• Middle East and Africa

Request Sample Copy Of This Report @ https://virtuemarketresearch.com/report/ionizing-breast-imaging-technology-market/request-sample